Situation:
A rapidly growing global pharma company had new development leadership coming in anticipation of numerous acquisitions and wanted to identify and close areas of weakness.
Solutions:
A gap analysis identified a Clinical Trial Management System that had never been implemented and a six-year-old merger that had not been adequately completed. Multiple areas of redundancy and siloed operations kept both efficiency and quality at risk.
- Halloran consultants led the integration of disparate quality systems between EU and US operations, and completed the project within eight months.
- During the integration, Halloran identified optimization opportunities to streamline efficiencies between the operating units.
- For ongoing acquisitions, Halloran identifies the delta between new and existing company systems.
Value:
Management met its objectives to harmonize global operations within a tight timeline and now has a framework to integrate additional acquisitions.